| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1007/S12016-007-0012-0 |
| P698 | PubMed publication ID | 17916985 |
| P50 | author | Ronald A. Asherson | Q73406057 |
| Ricard Cervera i Segura | Q53547424 | ||
| P2860 | cites work | Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses | Q29619908 |
| Clinical classification of pulmonary hypertension. | Q30341846 | ||
| Increased serum levels of antibodies against human cytomegalovirus and prevalence of autoantibodies in systemic sclerosis | Q74456139 | ||
| Pulmonary arterial hypertension associated with autoimmune disease: a single medical center experience | Q83279267 | ||
| Primary pulmonary arterial hypertension and the systemic autoimmune diseases | Q83279282 | ||
| Nonthrombotic manifestations of the antiphospholipid syndrome: away from thrombosis? | Q83932212 | ||
| A case of primary antiphospholipid syndrome complicated with pulmonary hypertension | Q33340041 | ||
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
| HIV and autoimmunity | Q33348896 | ||
| Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients | Q33438663 | ||
| Raynaud's phenomenon as a manifestation of parvovirus B19 infection: case reports and review of parvovirus B19 rheumatic and vasculitic syndromes | Q33866419 | ||
| Parvovirus B19 infection of bone marrow in systemic sclerosis patients | Q33884596 | ||
| Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene | Q34142690 | ||
| Pulmonary hypertension in systemic lupus erythematosus. | Q34995801 | ||
| Antiendothelial cell antibodies in systemic lupus erythematosus | Q35172099 | ||
| Primary idiopathic pulmonary hypertension complicated by pulmonary arterial thrombosis. Association with antiphospholipid antibodies | Q36182733 | ||
| Autoimmunity and pulmonary hypertension: a perspective | Q36327473 | ||
| Chronic major-vessel thromboembolic pulmonary hypertension | Q37925636 | ||
| Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension | Q39463358 | ||
| Prevalence of antiphospholipid antibodies in systemic sclerosis and association with primitive pulmonary arterial hypertension and endothelial injury. | Q39716911 | ||
| Pulmonary hypertension in systemic lupus erythematosus: a report of three cases | Q41936622 | ||
| Localized scleroderma after infection with Epstein-Barr virus. | Q43519358 | ||
| Pulmonary hypertension in a lupus clinic: experience with twenty-four patients | Q43535847 | ||
| Genetic clues to the cause of primary pulmonary hypertension | Q43694990 | ||
| Experience and results with 150 pulmonary thromboendarterectomy operations over a 29-month period. | Q44237076 | ||
| Systemic sclerosis: another rheumatic disease associated with hepatitis C virus infection | Q45739965 | ||
| Hepatitis E virus and systemic sclerosis | Q45754208 | ||
| Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma. | Q54737464 | ||
| Pulmonary Hypertension after Splenectomy? | Q57824445 | ||
| High prevalence of antiphospholipid antibodies in precapillary pulmonary hypertension | Q58622198 | ||
| Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31–32 | Q59674443 | ||
| Fatal primary pulmonary hypertension in a 30‐yr-old female with APECED syndrome | Q59697434 | ||
| Autoantibodies in patients with primary pulmonary hypertension: association with anti-Ku | Q68043465 | ||
| Antinuclear antibodies in primary pulmonary hypertension | Q68978807 | ||
| Circulating lupus type anticoagulant and pulmonary hypertension associated with mixed connective tissue disease | Q70280157 | ||
| Anticardiolipin antibodies are associated with pulmonary hypertension in patients with mixed connective tissue disease or systemic lupus erythematosus | Q70679216 | ||
| Autoimmune aspects of primary pulmonary hypertension | Q70882293 | ||
| Primary antiphospholipid syndrome presenting as chronic thromboembolic pulmonary hypertension. Treatment with thromboendarterectomy | Q71322278 | ||
| Long‐term iloprost infusion therapy for severe pulmonary hypertension in patients with connective tissue diseases | Q71653928 | ||
| Pulmonary hypertension in systemic lupus erythematosus: a report of an autopsied case | Q71985523 | ||
| Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients | Q72764443 | ||
| Primary antiphospholipid syndrome and pulmonary hypertension with prolonged survival. A case report | Q73088925 | ||
| [A possible role of anti-endothelial cell antibody in the sera of MCTD patients on pulmonary vascular damage relating to pulmonary hypertension] | Q73115171 | ||
| P433 | issue | 2 | |
| P921 | main subject | pulmonary hypertension | Q1128595 |
| P304 | page(s) | 153-158 | |
| P577 | publication date | 2007-04-01 | |
| P1433 | published in | Clinical Reviews in Allergy & Immunology | Q1932354 |
| P1476 | title | Pulmonary hypertension, antiphospholipid antibodies, and syndromes | |
| P478 | volume | 32 |
| Q34414696 | Association between Sjogren's syndrome and respiratory failure: put airway, interstitia, and vessels close together: a national cohort study |
| Q85206714 | Association of IgA Anti-ß2 Glycoprotein I with Clinical and Laboratory Manifestations of Systemic Lupus Erythematosus |
| Q43941028 | Clinical features and independent predictors of pulmonary arterial hypertension in systemic lupus erythematosus |
| Q80439769 | Cutting edge issues in autoimmunity |
| Q38051350 | Platelets in pulmonary hypertension: a causative role or a simple association? |
| Q33435508 | Pulmonary hypertension imitating HELLP syndrome |
| Q47825970 | The frequency of anti-beta2-glycoprotein I antibodies is low and these antibodies are associated with pulmonary hypertension in mixed connective tissue disease. |
| Q40134592 | Vasculitis: current status and future directions |
Search more.